| Literature DB >> 32082622 |
Oleg V Mamontov1,2, Andrey V Kozlenok1, Alexei A Kamshilin3, Evgeny V Shlyakhto1,2.
Abstract
PURPOSE: Comprehensive study of autonomic regulation assessed during follow-up could provide new detailed information about the risks stratification for hypertensive patients. Therefore, we investigated the associations of these indices with death, stroke, and revascularization during the follow-up observation of 55 patients.Entities:
Year: 2019 PMID: 32082622 PMCID: PMC7012266 DOI: 10.1155/2019/8391924
Source DB: PubMed Journal: Cardiol Res Pract ISSN: 2090-0597 Impact factor: 1.866
Clinical characteristics of patients included in the study.
| Associated clinical condition (ACC) | Occurrence (%) (number of cases) | Mean age ± SD (years) |
|---|---|---|
| All ACC | 28 (51) | 62.6 ± 4.2 |
| Coronary heart disease | 25 (45) | 63.5 ± 4.2 |
| Myocardial infarction | 14 (25) | 64.7 ± 5.7 |
| Myocardial revascularization | 13 (24) | 60.8 ± 5.7 |
| Stroke | 2 (4) | 63.0 ± 8/4 |
| Severe atherosclerosis of brain arteries | 2 (4) | 57.5 ± 3.5 |
| Chronic kidney disease stage IV | 1 (2) | 84 |
| Without ACC | 27 (49) | 51.9 ± 9.9 |
Questionnaire of the secondary examinations of patients.
| Question | Possible answer | |
|---|---|---|
| 1 | Is patient alive? | Yes, no |
|
| ||
| 2 | Myocardial infarction | Yes, no |
| 3 | Stroke | Yes, no |
| 4 | Revascularization | Yes, no |
| 5 | New cases of diabetes mellitus | Yes, no |
|
| ||
| 6 | Regular use of antihypertensive drugs | Yes, no |
| 7 | The number of antihypertensive drugs, pcs | Value |
| 8 | Regular use of statins | Yes, no |
|
| ||
| 9 | Subjective assessment of well-being | From 1 to 5 |
| 10 | BP measurements at home: the mean of three last measures, mmHg | Value |
| 11 | The presence of hypertensive crises during the last three months | Yes, no |
| 12 | The level of total cholesterol in the last examination, mmol/l | Value |
Indices of systemic hemodynamics and autonomous regulation in patients with and without ACC during the initial examination.
| Parameter | Without ACC | With ACC |
|
|---|---|---|---|
| Systolic BP (mmHg) | 132 ± 16 | 134 ± 22 | 0.79 |
| Diastolic BP (mmHg) | 71 ± 11 | 65 ± 18 | 0.043 |
| Heart rate (beat/min) | 71 ± 11 | 66 ± 12 | 0.084 |
| Valsalva index (rel. un.) | 1.8 ± 0.4 | 1.51 ± 0.3 | 0.046 |
| Hand grip (mmHg) | 16.6 ± 6.7 | 14.1 ± 5.3 | 0.18 |
| Cold vasoconstriction (rel. un.) | 0.42 ± 0.15 | 0.29 ± 0.12 | 0.054 |
| ABR (ms/mmHg) | 7.8 ± 6.3 | 6.4 ± 4.0 | 0.31 |
Outcomes of monitoring hypertensive patients with and without ACC in the course of the follow-up observation.
| Outcome | Target organ damage ( | With associated clinical conditions ( | Significance of differences |
|---|---|---|---|
| Death | 0 | 5 |
|
| Myocardial infarction | 1 | 2 |
|
| Stroke | 2 | 4 |
|
| Revascularization | 1 | 5 |
|
| New cases of diabetes mellitus | 1 | 3 |
|
| Progression of hypertension | 4 | — |
Dynamics of arterial BP and TPR during 1 minute of the orthostasis in hypertensive patients without ACC at the time of initial examination.
| Progressive disease ( | Nonprogressive disease ( |
| |
|---|---|---|---|
| Change of diastolic BP (mmHg) | 6.64 ± 10.8 | 0.40 ± 6.3 | 0.05 |
| Total peripheral resistance (rel. un.) | 0.49 ± 0.80 | 0.05 ± 0.21 | 0.028 |